Using Photoreactive Probes to Identify Viable Drug Targets in Non-small Cell Lung Cancer

Yi Liao1

  • 1Department of Drug Discovery, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. Yi.Liao@moffitt.org.

Insights

Chemoproteomics now offers new tools to study protein interactions in cancer cells. A novel, efficient method using photoreactive probes and mass spectrometry enables rapid profiling of these interactions.

Area of Science:

  • Chemical biology
  • Proteomics
  • Mass spectrometry

Background:

  • Chemoproteomics advancements enable exploration of protein ligandability.
  • The ligandable proteome in cancer cells remains largely uncharacterized.
  • Novel chemical tools are needed to profile protein-ligand interactions in vivo.

Purpose of the Study:

  • To develop a practical and efficient sample processing method for chemoproteomic analysis.
  • To profile protein-ligand interactions in live cancer cells using photoreactive probes.
  • To enable identification of fragment-associated proteins via HPLC-MS/MS.

Main Methods:

  • Utilized fully functionalized photoreactive fragment-like probes.
  • Employed "on-bead" digestion and ZipTip desalting for sample preparation.
  • Integrated liquid chromatography-high-resolution-tandem mass spectrometry (HPLC-MS/MS) for analysis.

Main Results:

  • Enabled visualization of fragment-protein interactions using fluorescent imaging.
  • Facilitated identification of fragment-associated proteins.
  • Demonstrated efficient processing of approximately 16 samples within 3 days.

Conclusions:

  • The developed method provides a practical and efficient approach for chemoproteomic profiling.
  • This protocol accelerates the study of protein-ligand interactions in cancer cells.
  • The method allows for visualization and identification of protein-ligand interactions in native biological systems.

Related Concept Videos